These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
453 related items for PubMed ID: 16059734
1. Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder. Schneider T, Hein P, Michel-Reher MB, Michel MC. Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):71-8. PubMed ID: 16059734 [Abstract] [Full Text] [Related]
2. Regulation of bladder muscarinic receptor subtypes by experimental pathologies. Ruggieri MR, Braverman AS. Auton Autacoid Pharmacol; 2006 Jul; 26(3):311-25. PubMed ID: 16879497 [Abstract] [Full Text] [Related]
3. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland. Kobayashi F, Yageta Y, Segawa M, Matsuzawa S. Arzneimittelforschung; 2007 Jul; 57(2):92-100. PubMed ID: 17396619 [Abstract] [Full Text] [Related]
4. M2 and M3 muscarinic receptor activation of urinary bladder contractile signal transduction. I. Normal rat bladder. Braverman AS, Tibb AS, Ruggieri MR. J Pharmacol Exp Ther; 2006 Feb; 316(2):869-74. PubMed ID: 16243961 [Abstract] [Full Text] [Related]
6. Gender comparison of muscarinic receptor expression and function in rat and human urinary bladder: differential regulation of M2 and M3 receptors? Kories C, Czyborra C, Fetscher C, Schneider T, Krege S, Michel MC. Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):524-31. PubMed ID: 12669188 [Abstract] [Full Text] [Related]
9. Chronic administration of anticholinergics in rats induces a shift from muscarinic to purinergic transmission in the bladder wall. Uvin P, Boudes M, Menigoz A, Franken J, Pinto S, Gevaert T, Verplaetse R, Tytgat J, Vennekens R, Voets T, De Ridder D. Eur Urol; 2013 Sep; 64(3):502-10. PubMed ID: 23711542 [Abstract] [Full Text] [Related]
11. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists. Gillberg PG, Sundquist S, Nilvebrant L. Eur J Pharmacol; 1998 May 22; 349(2-3):285-92. PubMed ID: 9671109 [Abstract] [Full Text] [Related]
14. Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents. Ohtake A, Saitoh C, Yuyama H, Ukai M, Okutsu H, Noguchi Y, Hatanaka T, Suzuki M, Sato S, Sasamata M, Miyata K. Biol Pharm Bull; 2007 Jan 22; 30(1):54-8. PubMed ID: 17202659 [Abstract] [Full Text] [Related]
15. Mechanisms mediating cholinergic antral circular smooth muscle contraction in rats. Wrzos HF, Tandon T, Ouyang A. World J Gastroenterol; 2004 Nov 15; 10(22):3292-8. PubMed ID: 15484303 [Abstract] [Full Text] [Related]
18. The role of M(2)-muscarinic receptors in mediating contraction of the pig urinary bladder in vitro. Yamanishi T, Chapple CR, Yasuda K, Chess-Williams R. Br J Pharmacol; 2000 Dec 15; 131(7):1482-8. PubMed ID: 11090124 [Abstract] [Full Text] [Related]
20. Muscarinic receptor subtypes in the submandibular gland and the urinary bladder of the rabbit: in vivo and in vitro functional comparisons of receptor antagonists. Tobin G. J Auton Pharmacol; 1995 Dec 15; 15(6):451-63. PubMed ID: 8920162 [Abstract] [Full Text] [Related] Page: [Next] [New Search]